New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.
Background Needle exchange programmes (NEP) provide injection drug users (IDU) with sterile injection equipment and receive used needles in exchange.
In this paper we describe the use of new syringes and NEP by IDU and characteristics associated with using NEP in 1993.
Methods Street-recruited IDU were interviewed in five US locations :
New York City, and Los Angeles (LA) county.
Results Most (75-95%) reported it was easy to get a new syringe and for their last injection, 45-77% used a new syringe and 2-18% used a syringe previously used by another IDU.
Use of NEP ranged from 8% to 16% in Chicago, Philadelphia, and LA County.
In LA County not having injected'speedball'in the last 30 days, last injection with a new syringe, and reporting it was very easy to get a new syringe were associated with NEP use.
In Philadelphia, NEP use was associated with'speedball'injection in the last 30 days, and in Chicago, not injecting with'speedball'and injecting with cocaine were associated with NEP use.
Conclusions In 1993, most street-recruited IDU in Chicago, Philadelphia, and LA County had not used NEP.
Factors associated with NEP use were not consistent across sites.
Dispersion of NEP and removal of legal barriers restricting access to sterile syringes may be more important in increasing the use of sterile syringes and NEP than client characteristics.
Mots-clés Pascal : SIDA, Virose, Infection, Virus immunodéficience humaine, Lentivirus, Retroviridae, Virus, Prévention, Toxicomanie, Voie intraveineuse, Programme sanitaire, Seringue, Echange, Epidémiologie, Evaluation, Homme, Etats Unis, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Human immunodeficiency virus, Lentivirus, Retroviridae, Virus, Prevention, Drug addiction, Intravenous administration, Sanitary program, Syringe, Exchange, Epidemiology, Evaluation, Human, United States, North America, America, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0251621
Code Inist : 002B06D01. Création : 11/09/1998.